LaRDR was well represented at the recent BLOOD conference held in Brisbane from 21-24 October 2018.
A LaRDR interest group breakfast meeting was attended by clinicians, industry and registry staff. Guests were treated to updates on registry progress (recruitment has reached nearly 1500 patients) and partnerships (including the Melbourne Genomics Health Alliance, presented by A/Prof Jake Shortt, and the Australasian Lymphoma Alliance presented by Dr Greg Hapgood, on behalf of ALA chair A/Prof Eliza Hawkes). The presentations were followed by open time for discussion.
In the scientific programme, Dr Michael Dickinson made an oral presentation titled “Progression-free survival in diffuse large B-cell lymphoma (DLBCL): early results from the recently established Lymphoma and Related Diseases Registry” and A/Prof Dipti Talaulikar presented a poster on progress with pathology review for LaRDR cases. The LaRDR team collaborated on a validation study with the Whimsical/Cartwheel Waldenstrom macroglobulinaemia registry, which was presented as a poster by Dr Ke Xu and colleagues.